Aura Biosciences, Inc.
Total Trades
45
Buys
10
Sells
31
Largest Trade
$1M+
Insiders
11
Institutional Funds
82
Inst. Value
$1M+
Activist Filings
32
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Kilroy Conor | See Remarks | SELL | $50K–$100K | 12K | $5.05 | Feb 18, 2026 |
| Plavsic Mark | CTO | SELL | $50K–$100K | 16K | $5.05 | Feb 18, 2026 |
| Hopkins Janet Jill | Chief Medical Offi… | SELL | $100K–$500K | 20K | $5.06 | Feb 18, 2026 |
| Elazzouzi Amy | Senior Vice President | SELL | $15K–$50K | 9K | $5.06 | Feb 18, 2026 |
| de los Pinos Elisabet | See Remarks | SELL | $100K–$500K | 48K | $5.06 | Feb 18, 2026 |
| Elazzouzi Amy | Senior Vice President | SELL | $1K–$15K | 2K | $4.86 | Jan 20, 2026 |
| de los Pinos Elisabet | See Remarks | SELL | $50K–$100K | 17K | $4.86 | Jan 20, 2026 |
| Hopkins Janet Jill | Chief Medical Offi… | SELL | $50K–$100K | 17K | $5.42 | Nov 17, 2025 |
| Elazzouzi Amy | Senior Vice President | SELL | $1K–$15K | 896 | $6.35 | Oct 29, 2025 |
| de los Pinos Elisabet | See Remarks | SELL | $50K–$100K | 9K | $6.35 | Oct 29, 2025 |
| Johnson David Michael | Director | BUY | $50K–$100K | 20K | $4.90 | May 20, 2025 |
| Gibney Anthony S | See Remarks | SELL | $1K–$15K | 2K | $5.15 | May 20, 2025 |
| Gibney Anthony S | See Remarks | BUY | $100K–$500K | 50K | $4.90 | May 20, 2025 |
| Elazzouzi Amy | Senior Vice President | SELL | $1K–$15K | 897 | $5.49 | Apr 17, 2025 |
| Kilroy Conor | See Remarks | SELL | $15K–$50K | 7K | $5.49 | Apr 17, 2025 |
| de los Pinos Elisabet | See Remarks | SELL | $100K–$500K | 16K | $7.67 | Jan 22, 2025 |
| Elazzouzi Amy | Vice President | SELL | $1K–$15K | 1K | $7.67 | Jan 22, 2025 |
| Hopkins Janet Jill | Chief Medical Offi… | SELL | $100K–$500K | 12K | $9.36 | Nov 19, 2024 |
| de los Pinos Elisabet | See Remarks | SELL | $50K–$100K | 9K | $10.74 | Oct 30, 2024 |
| Elazzouzi Amy | Vice President | SELL | $1K–$15K | 553 | $10.74 | Oct 30, 2024 |
| Feder Julie B | CFO | EXERCISE | $50K–$100K | 25K | $3.44 | Oct 21, 2024 |
| Feder Julie B | CFO | SELL | $100K–$500K | 25K | $12.03 | Oct 21, 2024 |
| de los Pinos Elisabet | See Remarks | EXERCISE | $50K–$100K | 25K | $2.74 | Oct 19, 2024 |
| de los Pinos Elisabet | See Remarks | SELL | $100K–$500K | 25K | $12.04 | Oct 19, 2024 |
| Plavsic Mark | CTO | SELL | $50K–$100K | 7K | $9.85 | Oct 17, 2024 |
| de los Pinos Elisabet | See Remarks | SELL | $100K–$500K | 16K | $7.64 | Jan 24, 2024 |
| Feder Julie B | CFO | SELL | $50K–$100K | 7K | $7.64 | Jan 24, 2024 |
| Johnson David Michael | Director | BUY | $1M+ | 200K | $7.19 | Nov 9, 2023 |
| Matrix Capital Management Company, LP | 10% Owner | BUY | $1M+ | 1.6M | $9.00 | Nov 9, 2023 |
| de los Pinos Elisabet | See Remarks | SELL | $50K–$100K | 7K | $12.03 | Nov 7, 2023 |
| de los Pinos Elisabet | See Remarks | EXERCISE | $1K–$15K | 4K | $2.74 | Nov 7, 2023 |
| Feder Julie B | CFO | SELL | $15K–$50K | 4K | $12.07 | Nov 7, 2023 |
| Feder Julie B | CFO | EXERCISE | $1K–$15K | 4K | $2.74 | Nov 7, 2023 |
| Feder Julie B | CFO | SELL | $15K–$50K | 3K | $6.82 | Nov 1, 2023 |
| de los Pinos Elisabet | See Remarks | SELL | $50K–$100K | 10K | $6.83 | Nov 1, 2023 |
| Johnson David Michael | Director | BUY | $100K–$500K | 20K | $8.38 | Oct 5, 2023 |
| Johnson David Michael | Director | BUY | $15K–$50K | 2K | $10.41 | Jan 9, 2023 |
| Johnson David Michael | Director | BUY | $15K–$50K | 4K | $9.75 | Dec 31, 2022 |
| Johnson David Michael | Director | BUY | $100K–$500K | 10K | $12.37 | Dec 15, 2022 |
| Matrix Capital Management Company, LP | 10% Owner | BUY | $1M+ | 1.3M | $12.00 | Dec 7, 2022 |
| Feder Julie B | CFO | SELL | $15K–$50K | 2K | $12.45 | Nov 3, 2022 |
| Rich Cadmus | See Remarks | SELL | $15K–$50K | 2K | $12.45 | Nov 3, 2022 |
| de los Pinos Elisabet | See Remarks | SELL | $50K–$100K | 6K | $12.46 | Nov 3, 2022 |
| De Rosch Mark | COO | SELL | $1K–$15K | 1K | $12.46 | Nov 3, 2022 |
| Johnson David Michael | Director | BUY | $500K+ | 50K | $14.33 | Jun 15, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 82 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Matrix Capital Management Company, LP | 6.9M | $1M+ | SH |
| Frazier Life Sciences Management, L.P. | 5.1M | $1M+ | SH |
| Medicxi Ventures Management (Jersey) Ltd | 3.0M | $1M+ | SH |
| Nantahala Capital Management, LLC | 2.1M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1M | $1M+ | SH |
| LEVIN CAPITAL STRATEGIES, L.P. | 1.0M | $1M+ | SH |
| STATE STREET CORP | 927K | $1M+ | SH |
| Regency Capital Management Inc.\DE | 539K | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 463K | $1M+ | SH |
| Decheng Capital LLC | 360K | $1M+ | SH |
| VANGUARD GROUP INC | 359K | $1M+ | SH |
| UBS Group AG | 172K | $500K+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 145K | $500K+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 135K | $500K+ | SH |
| BNP PARIBAS FINANCIAL MARKETS | 115K | $500K+ | SH |
| PLATINUM INVESTMENT MANAGEMENT LTD | 112K | $500K+ | SH |
| Permanent Capital Management, LP | 76K | $100K–$500K | SH |
| BARCLAYS PLC | 69K | $100K–$500K | SH |
| RHUMBLINE ADVISERS | 65K | $100K–$500K | SH |
| TBH Global Asset Management, LLC | 60K | $100K–$500K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 18, 2026
3.3%
2.0M shares
Frazier Life Sciences Public Fund, L.P.
SC 13G/A · Feb 13, 2026
6.3%
4.0M shares
SC 13G · Oct 17, 2025
5.4%
3.3M shares
Frazier Life Sciences Public Fund, L.P.
SC 13G/A · Aug 14, 2025
5.0%
3.1M shares
Suvretta Capital Management, LLC
SC 13G/A · Aug 14, 2025
7.6%
4.7M shares
SC 13G/A · Jul 16, 2025
4.9%
3.0M shares
Frazier Life Sciences Public Fund, L.P.
SC 13G · May 23, 2025
6.1%
3.9M shares
Matrix Capital Management Company LP
SC 13D/A · May 19, 2025
11.2%
6.9M shares
LONG FOCUS CAPITAL MANAGEMENT, LLC
SC 13G/A · May 15, 2025
6.6%
3.3M shares
Eventide Asset Management, LLC
SC 13G/A · May 14, 2025
0.0%
0 shares
Eventide Asset Management, LLC
SC 13G/A · May 13, 2025
0.0%
0 shares
SUVRETTA CAPITAL MANAGEMENT, LLC
SC 13G · Apr 11, 2025
6.1%
3.1M shares
Eventide Asset Management, LLC
SC 13G/A · Feb 14, 2025
8.2%
4.1M shares
LONG FOCUS CAPITAL MANAGEMENT, LLC
SC 13G/A · Jan 4, 2025
5.0%
2.5M shares
LONG FOCUS CAPITAL MANAGEMENT, LLC
SC 13G · Jan 3, 2025
3.6%
2.5M shares
SC 13G/A · Nov 14, 2024
3.5%
1.8M shares
SC 13G/A · Nov 14, 2024
0.0%
6 shares
Adage Capital Management, L.P.
SC 13G/A · Nov 12, 2024
9.8%
4.9M shares
SC 13G · Nov 8, 2024
6.4%
3.2M shares
SC 13G · Oct 22, 2024
6.4%
3.2M shares
SC 13G/A · Feb 14, 2024
7.2%
6 shares
Eventide Asset Management, LLC
SC 13G/A · Dec 11, 2023
11.8%
5.8M shares
Matrix Capital Management Company LP
SC 13D/A · Nov 9, 2023
14.1%
6.9M shares
Eventide Asset Management, LLC
SC 13G · Feb 14, 2023
6.3%
2.3M shares
SC 13G/A · Feb 14, 2023
7.4%
6 shares
SC 13G/A · Feb 10, 2023
4.1%
1.5M shares
SC 13G/A · Jan 20, 2023
3.3%
1.2M shares
SC 13G · Dec 15, 2022
5.7%
2.1M shares
SC 13G/A · Feb 14, 2022
7.9%
6 shares
SC 13G · Feb 11, 2022
6.9%
2.0M shares
SC 13G/A · Feb 10, 2022
0.0%
1.6M shares
Lundbeckfond Invest A/S (“Lundbeckfond”)
SC 13G · Jan 26, 2022
6.9%
2.0M shares